U

UntilLabs

Advances reversible organ cryopreservation technology

Cardiac Preservation Scientist - Cardiac Preservation, Organ Perfusion

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeCalifornia, USAIn-person

About the Job

Requirements

  • Deep, hands-on expertise in ex vivo heart perfusion, ideally including normothermic machine perfusion (NMP) of the heart
  • Intimate understanding of cardiac physiology and biology, including myocardial metabolism, contractile function, and ischemia/reperfusion injury
  • Experience designing and running organ viability assessments and interpreting multimodal readouts (functional, metabolic, histological, omics)
  • Comfort working at the bench in an ex vivo model and a track record of executing complex experimental protocols
  • Demonstrated success working through hard, open-ended problems, with a passion for rapid problem solving and rapid exploration of unfamiliar topics and protocols
  • Ability to think from first principles and tackle complex, cross-disciplinary problems alongside other scientists and engineers

Responsibilities

  • Develop and execute ex vivo heart perfusion protocols, including normothermic machine perfusion (NMP), to maintain and evaluate cardiac viability before and after cryopreservation
  • Build out the heart viability assessment toolkit, including contractile and hemodynamic function, perfusion metrics, metabolic and lactate profiling, histology, and omics
  • Propose and test adjustments to cryoprotectant formulations, loading/unloading, cooling, and rewarming protocols to optimize cardiac health and recovery
  • Translate detailed knowledge of cardiac physiology and biology into experimental design and interpretation across the team

Desired Qualifications

  • PhD in a STEM field, ideally in cardiac physiology, organ preservation, or transplant — or significant (4+ years) experience as a scientific leader in an industry context
  • Direct experience with cardiac transplant or heart preservation research

About the Company

UntilLabs

Advances reversible organ cryopreservation technology

UntilLabs develops reversible cryopreservation technology to extend the viability of human organs for transplantation. The goal is to keep organs alive at cryogenic temperatures long enough to improve organ matching and reduce waste from time limits, potentially weeks or months of preserved time. The approach uses cooling to very low temperatures (below -130°C) with cryoprotectants to prevent ice damage, followed by advanced warming methods to revive the organs without harm. While cryopreservation has worked for cells and simple tissues, UntilLabs works on scaling this to whole organs, tackling challenges like ice formation and nutrient/waste management in large tissues. In the long term, the company envisions whole-body reversible cryopreservation as a bridge to future medical cures.

Company size
51-200
Company stage
Series A
Total funding
$58M
Headquarters
San Francisco, CA
Founded
2024

Recently Posted Jobs

Explore more opportunities at UntilLabs

See more jobs